Page-TitleABOUT
non-opiod pain relief

REINVENTING HOW HEALTHCARE PROFESSIONALS AND PATIENTS MANAGE PAIN

Virpax Pharmaceuticals is committed to developing products that effectively manage pain in all its complexities, while minimizing risks to patients and society. Pain is a universal condition, while the perception of pain is unique.

We are dedicated to creating novel treatment options for the management of pain. By combining innovative drug compounds with cutting-edge delivery systems, we strive to maximize our products’ capabilities and successfully bring them to market.

NON-ADDICTIVE PRODUCTS

We are developing numerous strategies that will address the rising need for alternatives to addictive opioid prescription medications. Our non-addictive products harness the improved characteristics of transdermal and liposomal drug-delivery technologies to target pain at its source. By focusing on these new drug-loaded delivery systems, we aim to increase product compliance and maximize the ability to achieve full therapeutic efficacy.

DEVELOPING BETTER OPTIONS

Our main purpose is to provide healthcare professionals and patients with new effective solutions to manage and control pain, whether acute or chronic, and to do so quickly in order to facilitate better practices for pain management worldwide.

CalloutIMPROVEDDRUG-DELIVERYSYSTEMS

“Biopharma companies have a deep understanding of the R&D of novel products, making the industry essential to the advancement of public health initiatives.”

ANTHONY P. MACK
CEO of Virpax Pharmaceuticals

INNOVATIVE TECHNOLOGIES

Utilizing the latest medical advancements, our innovative molecular technologies are being developed to increase compliance and maximize the patient’s ability to achieve full therapeutic efficacy.

REINVENTING PAIN RELIEF

Transdermal and topical delivery systems will reinvent how patients and prescribers manage pain worldwide. We are developing novel compounds and adding innovation to established FDA approved treatments with improved formulations and better attributes.

TREATING MULTIPLE INDICATIONS

Our first-in-class transdermal spray film technology with delivery molecules is being developed to manage acute and chronic pain. The non-opioid molecules are also effective in treating central nervous system and inflammatory diseases.

CalloutPRESCRIBERS AND PATIENTS ARESEEKING ALTERNATIVESTO CURRENT PAIN TREATMENTS
SubheadAREAS OF FOCUS

We are developing novel drug delivery systems and continuously seeking patents in various therapeutic areas.

Art

BRINGING THE BEST MINDS TOGETHER

Our team has over 100 years of combined executive experience in the pharmaceutical industry and extensive knowledge in developing and commercializing pain management products.

Learn more

DISCOVER THE BENEFITS OF OUR LATEST TECHNOLOGY ADVANCEMENTS

LEARN MORE